DKSH promotes pharmaceutical portfolio at CPhI Worldwide

Published: 5-Sep-2016
Ingredients Marketing

DKSH, the leading market expansion services provider with a focus on Asia, showcases its pharmaceutical portfolio, innovations, solutions and concepts at CPhI Worldwide 2016 in Barcelona, Spain

DKSH Business Unit Performance Materials, a leading market expansion services provider and distributor of pharmaceutical products (APIs, excipients, intermediates) will exhibit at CPhI Worldwide 2016 in Barcelona.

The event, which brings together the pharmaceutical industry’s leading companies, developers and experts will be held at the Fira Barcelona Gran Via from 4–6 October 2016.

DKSH will exhibit at stand 4H76, where we will be showcasing our expertise in packaging materials as well as final dosage forms. Its core competencies include global sourcing, regulatory affairs, quality control and global logistics.

'We very much look forward to once again showcase our extensive product and innovation concepts portfolio for the pharmaceutical industry at CPhI Worldwide 2016. Our presence as an exhibitor at the show will further broaden awareness of DKSH in the industry,' commented Tanja Schaffer, Vice President, Global Pharmaceutical Industry, Performance Materials at DKSH.

  • Companies:
  • DKSH Performance Materials
See more

You may also like

Ingredients

Biocon collaborates to commercialise generic formulas in South East Asia

Read more
Biocon Pharma and DKSH Business Unit Healthcare have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic formulations in Singapore and Thailand

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. Assessing the risks: the importance of a multifaceted approach to containment Risk assessment is a crucial component of any manufacturing process and plays a key role in terms of ensuring the well-being of workers and the quality of products, reports Gabriela Mikhaiel, Global Marketing and Communication Manager at Dec Group
  3. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  4. Tagrisso receives full approval in the EU For patients with locally-advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The pros and cons of distribution agreements For life sciences companies seeking to break into overseas markets, distribution agreements are central to success

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

You may also like

Ingredients

Biocon collaborates to commercialise generic formulas in South East Asia

Biocon Pharma and DKSH Business Unit Healthcare have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic formulations in Singapore and Thailand
Ingredients

DKSH signs exclusive distribution agreement with Abitec

The ingredients and specialty chemicals distributor has been selected to exclusively distribute a lipid excipient and nutritional supplement range in Thailand, Spain and Portugal
Distribution

DKSH extends performance materials business to Cambodia

With this expansion, DKSH Business Unit Performance Materials increases its geographic footprint to 31 countries
Ingredients

DKSH acquires Swiss specialty chemicals distributor

The acquisition of Staerkle & Nagler will extend DKSH\'s reach into Europe
Ingredients

DKSH signs agreement with Hanseo Chemical

To distribute glycerophosphatidylcholin (GPC) to the pharmaceutical industry worldwide
Ingredients

DKSH acquires Tiger Chemicals Company

Strengthens its footprint in Australia and New Zealand
Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Subscribe now